AMMG Presents 3 Days of Compelling General Session Lectures at their April 2026 Miami Meeting
Jeff Morris
From metabolic engineering to therapeutic plasma exchange, gut health to hyperbaric medicine, and senescent cell therapies to the danger lurking in hormone therapy, the 40th Clinical Applications for Age Management Medicine Conference will have something for everyone.
At the conference, held April 15-19, 2026 at the National Doral Miami Resort & Spa, AMMG will offer three days of compelling General Session lectures, following five intensive full-day and two half-day pre-conference workshops covering a wide range of topics. Registration is open at www.agemed.org.
A highlight on Friday will be two non-CME lectures. The Role of Metabolic Engineering in the Treatment of Chronic Disease and Aging, presented by Barry Sears, Ph.D., will cover metabolic dysfunction, the underlying cause of chronic disease and aging, and the dysregulation of the epigenetic control of key metabolic pathways that is its cause. Dr. Sears will talk about Metabolic Engineering, an integrated dietary program composed of a highly defined calorie restriction program coupled with adequate omega-3 fatty acid and polyphenol supplementation to activate AMPK and maintain it within a therapeutic zone necessary to epigenetically reprogram a disrupted metabolism. Published clinical data will be discussed. Dr. Sears is president of the Barry Sears Inflammation Research Foundation in Peabody, MA.
Also on Friday, Dr. Maureen Pickle, DMSc, MPH, PA-C, will present another non-CME lecture, Practical Applications for Supporting Immune Health, offering dynamic insight into the multilayered immune defense network. Dr. Pickle will cover the latest advancements in immune health, focusing on the gut-lung axis and the role of probiotics and more specifically immunobiotics in enhancing immune function.
Another practical, high-impact lecture on Friday is Demystifying Endotoxin: Identifying and Quenching the Fire Within-Clinical Tools to Reverse Neuroinflammation and LPS Burden, by Thomas O’Bryan, D.C., CCM. DACBN, CIFM. The lecture expands on the foundational science of endotoxin and focuses on clinical application: how to assess, intervene, and restore resilience in patients whose healthspan is silently eroding under the weight of chronic LPS driven inflammation.
Florence Comite, M.D., will talk about how technology and wearables are reshaping our understanding of metabolic health in an era where patients think they are doing all the right things, and yet are still sick under the surface; while Edwin Lee, M.D. will offer an Update of Senolytics and Rapamcyin in Reducing Biological Aging.
On Saturday, Pamela W. Smith, M.D. will present an interactive seminar focused on endocrine disrupting chemicals, in particular Bisphenol A. She will review the contemporary literature concerning toxin removal and heart disease, oncological diseases, inflammatory disorders, autoimmune processes, and other metabolic dysfunctions.
Jason Sonners, D.C., Ph.D., will offer brand new cutting-edge research in hyperbaric medicine. Derrick DeSilva, Jr., M.D., will talk about preventing sarcopenia resulting from the use of GLP-1 weight loss medication. Andrew W. Campbell, M.D. will present Gut Health: The Treatment and Reversal of Inflammatory Bowel Diseases: Crohn’s Disease, Ulcerative Colitis, SIBO, IBS, and Others. William Clearfield, D.O. will continue his Laboratory of Functional Medicine, while Mark L. Gordon, M.D. will discuss why “normal” laboratory values often fail to represent optimal health.
In another Saturday lecture, Jerry Mixon, M.D. will recap the benefits of reducing senescent cell load in Asian Americans and will address the latest research in finding less toxic methods for reducing senescent cell burden, including the literature on the dasatinib quercetin studies as well as the newer studies involving Fisetin.
And General Sessions continue on Sunday, when among the lectures, Carolyn DeLucia, M.D. will explore the intricate details and hidden dangers involved with prescribing HRT for women, since the FDA removed its black box warning on such therapy.
Further details on the entire conference agenda may be found at www.agemed.org.
;